findmyKOL
Clinical trialNCT01032291TerminatedPhase 2Interventional

A Study to Assess the Efficacy and Safety of Lenalidomide in Combination With Cetuximab in Pre-treated Patients With KRAS Mutant Colorectal Cancer

SponsorCelgene CorporationEnrollment51Colorectal Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Flinders Medical Centre, Dept. of Oncology

    Bedford Park, South Australia, Australia

Belgium
  • Uz Antwerpen Dept. of Medical Oncology

    Antwerp, Belgium

  • Ulb Erasme Service de Gastroenterologie

    Brussels, Belgium

  • Grand Hôpital de Charleroi, Oncologie

    Charleroi, Belgium

  • Algemeen Ziekenhuis Maria Middelares

    Ghent, Belgium

  • Universitaire Ziekenhuis Gasthuisberg K.U. Leuven Gastroenterologie, Oncologie

    Leuven, Belgium

  • Centre Hospitalier Universitaire Sart Tilman Liège

    Liège, Belgium

Germany
  • Klinikum Oldenburg Ggmbh Klinik Für Innere Medizin Ii

    Oldenburg, Lower Saxony, Germany

Italy
  • Azienda Osperdaliero Universitaria Riuniti Umberto I-Gm Lancisi-G. Salesi Di Ancona Clinica Di Oncologia Medica

    Ancona, Italy

  • Azienda Ospedaliera Universitaria San Martino Unità Operativa Oncologia Medica

    Genova, Italy

  • Azienda Ospedaliera Niguarda Ca' Grande, Oncologia Medica Falck

    Milan, Italy

Spain
  • Hospital Vall D'Hebron Servicio de Oncología. Unidad de Ensayos Clínicos

    Barcelona, Spain

  • Hospital Universitario Marques de Valdecilla Servicio de Oncología

    Santander, Spain

  • Hospital Clinico Universitario de Valencia Servicio de Oncologia

    Valencia, Spain

Sweden
  • Östra Sjukhuset Kirurgkliniken

    Gothenburg, Sweden

  • Karolinska University Hospital, Solna, Karolinska Institutet Dept of Oncology

    Stockholm, Sweden

  • Akademiska Sjukhuset Onkologkliniken

    Uppsala, Sweden

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Cetuximab →Lenalidomide →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 2009
Primary completion
31 Jan 2011
Completion
31 Jan 2011
Last update posted
21 May 2013
Registered enrollment
51
Registry id
NCT01032291

Cross-registrations

EU-CTR / CTIS (EudraCT)2009-012665-61
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.